07:00 , Apr 6, 2015 |  BioCentury  |  Emerging Company Profile

Treating H. pylori

ImevaX GmbH is developing a therapeutic vaccine against Helicobacter pylori that could be more effective than standard of care without generating resistance. The company also is developing two diagnostics for the bacterial infection, including a...